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CHAPTER 1 
Introduction 
Saturated fatty acids 
In recent years developing countries have transitioned into consuming 
foods low in nutrition and there is more and more tendency to eat calorie -dense 
foods instead of a healthy low fat, high fiber and low calorie based diet (1). As a 
consequence of these changes in food pattern, a significant increase in the 
number of people with the metabolic syndrome (which includes glucose 
intolerance, obesity, hypertension, insulin resistance, type 2 diabetes, 
dyslipidemia and cardiovascular disease) has been observed worldwide (2). 
Therefore, it is very important to identify the specific foods, nutrients or eating 
patterns which are associated with these metabolic abnormalities, so the 
necessary recommendations can be made to improve the dietary patterns for 
these people (2). Typically, these individuals have more than one risk factors of 
metabolic origin but the most predominant of them is obesity (3).Due to the 
specific effects, some fatty acids have on different metabolic activities, dietary fat 
composition can contribute to the development of obesity by changing fat 
oxidation, and thus influence both body weight and composition (3).Obesity- 
associated low grade chronic inflammation as manifested by macrophage 
infiltration in white adipose tissues is significantly related to high fat diets in human 
and animals (4). Lean and obese individuals do not seem to stimulate fat 
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oxidation in the same way when fed the high fat diets (5).Different types of dietary 
fats have a major impact in body fat increase (6).The deposition of body fat can 
increase significantly more with saturated fatty acids (SFAs) when compared to 
omega -3 and omega -6 rich diets (6).  
 Earlier study has shown that there have been specific effects observed on 
plasma cholesterol levels with different individual SFAs (7). Lauric acid (12:0), the 
predominant fatty acid in coconut oil, is the most potent SFA for increasing TC 
and LDL cholesterol levels (7).There are two other common SFAs which also 
raise blood cholesterol levels namely myristic (C14:0) and palmitic acids (C16:0) 
(7). 
Based on their origin, dietary SFAs can be categorized into two groups, 
animal fats and vegetable oils (8). Palm oil, soybean oil, palm kernel oil, coconut 
oil available from vegetable origin are high in SFAs (8). In western diets, the most 
common long-chain SFAs are stearic (C18:0) and palmitic (C16:0) acid which are 
considered as the main SFAs in human plasma and tissue as well (8). However 
each SFA is different based on their specific fatty acid profiles (9). Palm oil mainly 
consists of palmitic acid (C16:0) and oleic acid (18:1n-9) whereas coconut oil is 
high in lauric acid (C12:0) (9).    
According to the recommendation by Institute of Medicine calories from fat 
intake should be limited to 20% to 35% of total daily calorie intake and the 
average intake of SFA content should be less than 10% of total energy consumed 
(10) . 
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Stearic acid is a common fatty acid of all meats and dairy products, 
therefore the effect of stearic acid on metabolism need to be evaluated (11). Beef 
tallow generally contains 18% to 19% of stearic acid and is the major source of 
stearate in US diet (11). Results from previous study indicate that lean beef is no 
more considered as hypercholesterolemic and need not be taken out when trying 
to lower the cholesterol levels (11).    
All SFAs have their own characteristics, and are different based on their 
carbon chain lengths which affect their metabolism (12). SFAs contain carbon 
atoms between 12 and 24 with no double bond (12). Generally short chain fatty 
acids (SCFAs) contain two, three or four carbon atoms and liver can fast 
metabolize these SCFAs (12). Medium chain fatty acids (MCFAs) contain six, 
eight, ten or twelve carbon atoms and these are mostly found in butterfat and 
tropical oils like coconut oil, but not abundant in foods (12). These MCFAs are 
absorbed and carried directly to the liver and oxidized for energy (12). Long chain 
fatty acids (LCFAs) which contain 16 carbon atoms or more and will need more 
cleavage steps and decarboxylation during metabolism (13). Lard, beef tallow, 
soy, canola oil, cocoa butter are some of the common LCFAs that are used 
frequently (13). 
SCFAs and MCFAs have been identified as ‘anti-viral’ and ‘anti-bacterial’ 
and can be protective against viruses and bacteria which cause gastrointestinal 
damages and heart disease. In contrast LCFAs do not have this protective effect 
(14).  
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Body composition and dietary fatty acids 
In human body , 80-90% fat is stored in the subcutaneous depots (just 
under the skin, abdominal, gluteal-femoral) and rest of the 10-20% body fat is 
stored in the visceral depots (omental and mesenteric) (15) .  
Even though the ideal amount of body fat is a subjective measure, 
researchers agree that body fat excess of 22% of body weight for young men and 
32% for young women increases disease risks (16). If the excess fat is distributed 
around the trunk of the body which is known as central or visceral obesity 
(apple-shaped, mainly found in man) , it presents even greater risks for diseases  
(diabetes, stroke, heart disease, hypertension ) than if it is on the lower body 
(pear-shaped, mainly found in woman) (16). Earlier study has shown that different 
dietary fat influence the location of fat in the body and there is a strong correlation 
between central obesity and cardiovascular disease (17).  
Previous study has shown that diets rich in polyunsaturated fatty acids 
(PUFAs) can be helpful in lowering abdominal fat due to a higher rate of oxidation 
of PUFAs (18). Depending on the need of body, carbohydrates can also be 
metabolized into fatty acids but the efficiency of the deposition of individual dietary 
fatty acids is higher when comparing to the deposition of de novo synthesized 
fatty acids (19).  
According to a study by Flatt et al (20), total energy intake and expenditure 
determine the amount of energy stored in the adipose tissue. However types of 
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diets also have a great impact on this effect as well. Several metabolic changes 
are strongly related to high fat diets such as decreased lipolytic activity and 
decreased leptin concentration (21), obesity and insulin resistance (22).  
Dietary fatty acid intake and lipid metabolism 
Considering the CVD risk factors, it is now a known fact that the ‘type’ of 
dietary fat has greater impact on CVD risk than the amount (23).The effects of 
dietary SFA on plasma lipoproteins associated with CVD risk are by elevating 
LDL-cholesterol concentration (23).It has been shown that using of SFAs instead 
of PUFA, increases total LDL and HDL cholesterol levels (24). 
Another study by Montoy et al (25) examined the effects of individual fatty 
acids on lipid metabolism. They gave four different types of diets containing SFAs 
(palm oil), MUFAs (olive oil), n-6 PUFAs fat diet (sunflower diet) and n-3 PUFAs 
diet (sunflower oil supplemented with fish oil). According to their results, PUFAs 
and MUFAs produced a better lipid profile compare to SFAs. Furthermore, the 
effects of SFAs on lipids and lipoproteins can be determined by the amount of 
PUFAs in the diet (26). LDL cholesterol level is affected by SFAs if the PUFAs 
intake is below a threshold level (~ 5% of energy) (26).There are also indications 
from earlier studies that individual types of SFAs will affect LDL and HDL 
cholesterol differently (27). If carbohydrate (CHO) is substituted with SFAs of long 
chain length, there is a little increase in LDL cholesterol levels. Among the SFAs, 
lauric acid had significantly higher increase in cholesterol concentration compared 
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to stearic acid (27). 
Leptin 
In energy metabolism as well as lipid and glucose homeostasis, white   
adipose tissue plays an important role by producing hormones such as leptin and 
adiponectin to regulate food intake and metabolism (28). In recent years 
researchers have shown growing interest in obesity genetics because of the 
identification and sequencing of OB (Lep) gene, which was discovered in 1994 
and it is located on chromosome 7 in humans (29). There is a rapid increase in 
obesity during the last several decades. But only a small portion of this increase 
can be explained by genetic alterations (30). The majority of this increase is due 
to other reasons, such as changes in diet, habits and lack of exercise (30).  
It is well established that in regulating energy intake and expenditure, leptin 
is known to reduce food intake by transmitting a satiety signal to the central 
nervous system and increase metabolism and energy expenditure by increasing 
thermogenesis (30). Previous study has indicated that there was an increase in 
leptin level in obese population with insulin resistance and dyslipidemia (30).This 
increase in serum leptin concentration (hyperleptinemia) has been suggested to 
be caused by leptin resistance (31). Hypertension, impaired glucose metabolism, 
and pro-atherogenic condition could be influenced by hyperleptinemia as well 
(32). Leptin is also responsible for the function of growth and reproduction system 
(33). Leptin decreases pancreatic beta cell production of insulin and enhances 
insulin action (34).   
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Adiponectin 
Adiponectin is a protein product from chromosome 3q27.It is secreted by 
adipocytes and it regulates glucose levels and fatty acid breakdown but the 
specific signaling pathways that regulate the different metabolic effects of 
adiponectin are still not identified clearly (35). Adiponectin is a key factor in down 
regulating various metabolic functions which may cause obesity, type 2 diabetes 
(T2DM), atherosclerosis and non –alcoholic fatty liver disease (NAFLD) (36). Lack 
of adiponectin is also an independent risk factor for metabolic syndrome (36). 
Previous study has shown that in patients with cardiovascular disease,   
hypertension and obesity, plasma adiponectin concentrations were decreased 
(37). Earlier study has reported that in mice, insulin resistance can be completely 
reversed if there is a combination of specific physiological doses of adiponectin 
and leptin administered at the same time (38).   
Insulin resistance and fatty acids 
Insulin resistance is a physiological condition when cells do not respond to 
the normal function of insulin, leading to hyperglycemia which is a significant risk 
factor for T2DM. Insulin resistance has also been implicated as an independent 
risk factor for CVD and is associated with other physiological abnormalities (39). 
Because insulin induces a number of metabolic responses, a defect or deficit in 
insulin signaling may cause adverse metabolic changes (40). The secretion of 
insulin by pancreatic beta cells decreases with age for humans and this decrease 
will cause hyperglycemia faster in individuals with insulin resistance (40). 
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Previous study has shown that high fat diet causes insulin resistance (41). 
According to a study by Ikemoto et al (42) the function of insulin could be 
influenced by individual fatty acid profile of the diet. Based on their study, diets 
high in different SFAs decrease the function of insulin. The mechanisms for how 
dietary fat types (quality) influence insulin sensitivity are not adequately and 
comprehensively understood yet (43). However, it is assumed that the effects of 
individual dietary fatty acids on this biological function are influenced by the 
characteristics of cell membranes and their FA components (43). Membrane 
fluidity and stiffness could change with a small modification of FA composition of 
the sarcolemma(43). The function of insulin could be influenced by a specific fatty 
acid like lauric or stearic acid, through changes in cell signaling pathways and 
differences in insulin receptor binding as well (43). 
Coconut oil 
Coconut oil is an edible oil, extracted from the kernel of mature coconuts 
and it has a long shelf life for up to two years in some cases, because of its low 
oxidation rate(44).It contains 91% saturated fat of which 60% is lauric acid (C: 12) 
(45). Regular coconut oil is not hydrogenated but when it is used as an ingredient 
in processed foods (like candy, cookie etc.), it is partially hydrogenated to 
increase its melting point for better shelf life (46). That’s when coconut oil 
becomes ‘bad’ food because partial hydrogenation produces trans fatty acids. For 
this reason researchers became concerned about the consumption of high 
amount of coconut oil (46). Earlier study (47) demonstrated that lauric acid raises 
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blood cholesterol levels markedly which led to the belief that tropical oils 
contribute to CVD. Much of this increase in blood cholesterol levels are due to 
increase in LDL and HDL cholesterol. However, it also decreases the total 
cholesterol and HDL ratio so lauric acid may causes CVD through pathways not 
related to HDL levels (47). By increasing concentrations of cholesterol and 
phospholipids, coconut oil causes hyperlipidemia (48). Another study in rabbits 
observed that the rabbits fed with isocaloric coconut oil had symptoms of 
atherosclerosis and metabolic syndrome without any obvious weight gain 
compared to the rabbits that were given only standard chow diet (49). 
Beef tallow 
Tallow is an animal fat processed from suet and currently in United States, 
most of the tallow comes from edible/inedible rendering industries, meat packing 
and poultry industries (50). Basically inedible tallow is used as a supplement for 
animal feed and also used in soap, lubricants etc (50). It contains mostly 
triglycerides (fat), consisting of mainly stearic (C18:0) and oleic (C18:1n-9) acids 
(51). For meat industries, beef tallow is one of the most important by-products 
(51). For high heat cooking this is one of the best fats because of its high smoking 
point (4000-4500 F) and can avoid generating free radicals (52). Oxidation causes 
free radicals that damage tissues, cells and organs in the body (52).     
Previous study has shown that beef tallow can protect animals from 
metastatic breast tumors (53). Based on their report, the function of conjugated 
linoleic acid (CLA) was not affected by other fatty acids (palmitic, oleic and 
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stearic) in beef tallow. There was a clear indication that dietary beef tallow, even 
though contains only little amount of CLA, is capable of increasing the efficiency 
and efficacy of dietary CLA and decreasing the incidence of tumorigenesis (53). 
Finally, according to a study by German et al (54), for individual SFAs 
intakes (lauric, stearic, palmitic, myristic etc.), there is no safe limit that can be 
recommended for individuals who are from different background and maintaining 
different lifestyle. The significance of different type of fatty acids in different 
individuals is not well studied. An extensive research should be conducted for 
such determination taking into account the variance of individual differences. 
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CHAPTER 2 
Objectives of this study 
The objectives of this study were to assess: 
1) The effects of both the quality (coconut oil & beef tallow) and quantity 
(low & high) of dietary fat on weight gain/loss in Wister rats. 
2) The blood profiles and metabolism of different types and quantity of 
dietary fat in Wister rats. 
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CHAPTER 3 
Methods 
Study design 
This study was based on a 2x2 factorial design to investigate the effects of 
both the quality (coconut oil and beef tallow) and quantity (high and low) of dietary 
fat. 
Animals 
Forty two male Wister rats were purchased from Harlan Sprague- Dawley 
(Indianapolis, IN) at eight weeks of age for this study. They were housed one per 
polycarbonate cage under standard laboratory conditions (room temperature, 
220-240 C, relative humidity, 50-52%, light dark cycle 12 : 12 hour). The animals 
were 80-100 grams on arrival and they were provided food and water ad libitum. 
After one week of adaptation, rats were randomly divided into four groups and 
received their respective diets: control low fat (CLF, n=10), control high fat (CHF, 
n=10), modified low fat (MLF, n=11), and modified high fat (MHF, n=11).  Animal 
care and handling were according to federal guidelines and under the 
administration of Division of Laboratory Animal Resources (DLAR), Wayne State 
University, and according to Animal Investigation Committee (AIC) approved 
protocol. 
Diet 
Rats were fed modified AIN -93M purified rodent diet as control low fat 
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(CLF, 40gm fat/kg with 30gm/kg from coconut oil and 10gm/kg soybean oil). High 
fat diet (CHF) contained 240gm/kg fat with 230gm/kg coconut oil, and 10gm/kg 
soybean oil. The modified low fat (MLF, 40gm/kg) contained 30gm/kg modified 
beef tallow, 10gm/kg soybean oil and modified high fat (MHF, 240gm/kg) with 
230gm/kg modified beef tallow, 10gm/kg soybean oil. All rats were fed their 
respective diets for ten weeks. All diets were commercially prepared in pellet form 
by Dyets, Inc. (Bethlehem, PA). The composition of the diets are listed in Table 1, 
and the fatty acid composition of the fats used is listed in Table 2. 
Procedure 
After one week of adaptation period all forty two rats were separated 
randomly into 4 groups. The groups were as follows: CLF (n=10), CHF (n=10), 
MLF (n=11) and MHF (n=11). Food intake and body weight were measured twice 
a week. Left-over foods were discarded and fresh food offered at each weighing. 
All foods were refrigerated at 40 C until use.  
Sacrifice procedure 
At the end of the 10 week feeding period, all rats were fasted overnight. 
The next morning, these rats were sacrificed by briefly exposing to carbon dioxide 
and then they were decapitated. Trunk blood was immediately collected in a tube 
containing 0.15% EDTA, vortexed and centrifuged at 1000xg for 20 min at 40 C. 
Plasma was collected and stored at -200 C for later biochemical analyses. Ten 
rats were killed each day.  
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The carcasses were eviscerated and the liver was removed and visible fat 
in the abdominal cavity was carefully collected, weighed and recorded as internal 
fat. Rest of the carcass was labeled and frozen for later body composition 
analysis. 
Biochemical Assays 
Blood parameters  
Plasma glucose, cholesterol, triglyceride were measured using kits 
purchased from Pointe Scientific INC (Canton, MI). Plasma leptin and insulin 
levels were determined by radioimmunoassay (RIA) techniques. The Rat Leptin 
RIA kit was purchased from Linco Research (St. Charles, Missouri). Insulin was 
measured by using a RIA kit purchased from ICN Pharmaceuticals, Inc. (Costa 
Mesa, CA). Insulin sensitivity was evaluated by the Homeostasis Model 
Assessment (HOMA) (55). Plasma adiponectin levels were assayed using a 
mouse adiponectin RIA kit purchased from Linco Research (St. Charles, 
Missouri).   
Body composition analysis 
Body composition analyses were completed on shaved and eviscerated 
carcasses according with the procedure described by Jen et al (56). All of the 
carcasses were autoclaved and homogenized. Then triplicate homogenate 
samples were taken to measure the lipid and water content. Total lipid content in 
the carcass was measured by the methods of Folch et al (57) and this lipid was 
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considered as the subcutaneous fat. The total fat content in each rat was 
determined by adding the internal fat and subcutaneous fat together. 
Statistical analysis 
Mean and standard error of the mean were calculated for every variable in 
this study. Factorial analysis of variance (ANOVA) was used to assess differences 
in body weight and food intake, plasma glucose, insulin, leptin, adiponectin, 
cholesterol, triglyceride and total fat content. Significance was set at p<0.05. All 
calculation/ analysis were performed using the SPSS version 22 (IBM SPSS Inc. 
Armonk, NY). Post-hoc comparisons (multiple comparison test) were performed 
when a significant effect was found to identify the specific groups that contributed 
to the difference.     
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CHAPTER 4 
Results 
Body weight   
Figure 1 shows the body weights of the four different groups of rats in 
grams. Increased body weight were observed throughout the experiment. MHF 
gained significantly lower than the CLF, CHF and MLF groups.  
Sacrifice weight   
At sacrifice both quality (Coconut (C): 527±46g, Modified beef tallow (M): 
472±62g, p< 0.0001) and quantity (Low fat (L): 521±41g, High fat (H): 475± 68g, 
p<0.002) contributed the body weight differences. A significant interaction was 
also observed (p<0.003). Fat quantity did not make a difference for rats fed the 
control diets (528±44g, 527±46g).However, rats fed the modified high fat diet 
(427±46g) weigh significantly less than those fed the modified low fat (516±40g) 
diet. 
Body composition 
 Figure 2 demonstrates the body fat as percent of total body weight   
observed in the 4 groups. Figure 3 demonstrates the total fat content observed in 
the 4 groups. Our data analysis indicated that both the quality (Control: 7.70 
±2.2% vs Modified: 6.41±2.2%, p<0.016) and the quantity (L: 7.79 ±1.66%, H: 
6.26±2.53%, p=0.009) influenced to the body fat percent. There was also a 
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significant interaction (p= 0.012) observed which indicates modified fat reduced 
body fat percent when the fat consumption was high as demonstrated by the fact 
that MHF (4.7±1.0%) had significantly less body fat percent than the other 3 
groups.  
Energy intake 
Figure 4 displays the total calorie intake among the four groups based on 
their respective diets. No significant differences (p>.05) were observed among the 
4 groups. 
Blood Cholesterol Levels  
Table 3 shows the plasma cholesterol levels observed in our study. 
Regardless of the quality and quantity of the oils used in the diets, there were no 
significant differences (p>.05) observed among the four groups.   
Blood Triglyceride Levels 
Triglyceride concentrations with different fatty acids were presented in 
Table 3. The amount of fat (L: 198±29 mg/dl, H: 189±62mg/dl) in the diet did not 
change the total TG levels. However modified fat significantly reduced TG levels 
compared to coconut oil (coconut oil: 234±18 mg/dl, modified fat: 157±36mg/dl, 
p<0.0001). The significant interaction (p<0.0001) indicates that MHF group had 
significantly lower TG than MLF group, but this effect was not observed in the 
coconut oil groups. 
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Glucose 
As shown in Table 3, Coconut and modified groups had similar glucose levels and 
therefore no significant difference (p>0.05) was observed regard to fasting plasma 
glucose. The amount of fat in the diets did not alter the blood glucose levels 
either.   
Insulin  
The effects of the four diets on insulin were shown in Table 3. There were 
significant differences (p=.026) observed between the coconut oil 
(51.9±8.0U/ml) and modified fat (44±10.8U/ml) groups. The amount of fat in the 
diets did not change the blood insulin levels. Insulin sensitivity was evaluated by 
Homeostasis Model Assessment (HOMA). The data showed that even though 
modified fat reduced the HOMA (CLF:35.9±7.1, CHF:33.1±6.4, MLF:29.9±6.0 
,MHF:32.2±16.5) the difference failed to reach significance. Neither the quality nor 
the quantity of the diet fats affected the insulin sensitivity. There was no 
interaction between quality and quantity of fat identified. 
Leptin  
Table 3 presents the plasma leptin concentration observed in the 4 groups. 
The modified fat significantly reduce (p=0.032) the leptin levels compare to 
coconut oil. The amount of fat in the diets did not alter blood leptin levels. There 
was a significant interaction (p=0.009) observed indicating that modified fat 
reduced leptin when the fat consumption was high, but would not affect leptin 
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levels when the fat consumption was in the normal range. Since the MHF had 
significantly lower body fat content, the leptin per gram of body fat was calculated. 
There was no difference among the four groups in leptin/body fat content. 
Therefore, the lower leptin level in the MHF group was due to the reduced body 
fat content, not due to changes in leptin sensitivity.  
Adiponectin 
Table 3 displays the change in plasma adiponectin levels among the four   
diet groups. From our results, it is clear that the type of fat (quality) influenced the 
adiponectin concentrations. The modified groups (8.81±2.14ng/ml) had 
significantly increased (p=0.03) adiponectin levels compared to Coconut groups 
(7.41±1.9ng/ml).The amount of fat did not contribute to the differences among the 
groups.  
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CHAPTER 5 
Discussion 
This study was conducted to determine the influence of different saturated 
fatty acids on body weight regulation and metabolism in Wister rats. Male Wister 
rats were fed diets made with either coconut oil (high in lauric acid 12:0) or a 
modified beef tallow (enriched with stearic acid 18:0) ad-lib for ten weeks. The 
results of our study demonstrated that the modified groups weighed significantly 
less than the Coconut groups. Percent body fat was shown to be lower in modified 
groups than the Coconut groups. We also observed that modified groups had 
significantly less triglyceride and insulin levels compare to Coconut groups. There 
were no differences observed with regard to energy intake, cholesterol and 
glucose levels. Modified group had significantly high levels of adiponectin and 
lower leptin than the Coconut groups. 
The role of SFAs as the main cause of cardiovascular disease has not 
been established beyond all reasonable doubt. Different saturated fats have 
different effects on human body. Results from our study demonstrated that MHF 
did not have an impact on plasma cholesterol even when fed at a high amount. An 
earlier study (58) showed that stearic acid (high in beef tallow) has a unique 
property of not raising plasma cholesterol concentration. The “neutral” or 
hypocholesterolemic effect of dietary stearic acid was confirmed by many earlier 
studies (58, 11). Our data support previous findings.  It is not clear if any adverse 
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effects on blood cholesterol levels will be observed when even higher amount of 
this modified fat is consumed. Further research with higher amount of stearic acid 
or longer period of feeding is warranted. 
The mechanisms as to why stearic acid as a SAF doesn’t raise blood 
cholesterols are still not clearly delineated. One of the possible explanations 
would be that stearic acid makes changes in the bile acid metabolism and reduce 
the production of hydrophobic secondary bile acids (59). Cholesterol is 
hydrophobic by nature. As a result of decreased bile hydrophobicity, the solubility 
of cholesterol is also reduced and thus reduces the absorption of cholesterol. 
Guerciolini et all (60) also indicated that if there is an imbalance between the fat 
and bile ratio, fat globules remain intact and cannot be emulsified inside the 
intestine. These fat globules are not absorbed at all and will pass through for fecal 
excretion. Imaizumi et al (61) did a study on hamsters and reported that the 
excretion of fecal fatty acids were significantly increased by feeding cholesterol 
free diets made with stearic acid (18:0) compared to diets made with lauric (12:0) 
acid. They also stated that because of the low absorption of stearic acid, it failed 
to raise plasma cholesterol levels. Feces were not collected in our study so we 
cannot infer any conclusion in this aspect. But we can relate the use of modified 
beef tallow with enriched stearic acid in our study which reflects no significant 
differences in cholesterol profile among the four diet groups (Table 3). We also 
speculate that poor absorption of stearic acid compare to lauric acid is the 
mechanism behind our findings. More specific studies are needed to confirm 
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these mechanisms in the future.    
The Coconut SFA used in this study is coconut oil which is high in lauric 
acid content. Although lauric acid is a medium chain fatty acid, previous study has 
classified lauric acid as a cholesterol raising saturated fatty acid (62), as it 
increases both LDL and HDL cholesterol concentration at the same time. Coconut 
oil also contain myristic acid (14:0) and palmitic acid (16:0) which have been 
identified as potential cholesterol raising fatty acids. Another study by Denke and 
Grundy (63) reported a strong correlation between LDL cholesterol and total 
cholesterol concentration based on the cholesterol raising SFAs (lauric and 
palmitic). But in the present study, when we compared coconut oil (lauric acid)   
and modified beef tallow (stearic acid), we did not observe any adverse effects of 
lauric acid on plasma cholesterol concentration. The reason for this discrepancy 
of current study and previous study deserves further investigation. 
A different study (64) showed that shortly after the absorption of beef 
tallow, stearic acid desaturates into oleic acid which is a monounsaturated fatty 
acid and does not raise cholesterol. On the other hand, for this type of 
desaturation, lauric acid (coconut oil) is not a good substrate. Based on the 
different chain length and degree of saturation point, each dietary fatty acid 
undergoes different metabolic pathways. After absorbed directly into the portal 
vain, MCFAs are then rapidly transported to the liver for next step which is 
“beta-oxidation”. Using this mechanism MCFA increases diet–induced 
thermogenesis. In contrast, LCFAs are absorbed via the intestinal lymphatic ducts 
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and then chylomicrons transport these LCFAs through the thoracic duct into the 
systemic circulation (65). These differences in the metabolic pathways influence 
the low absorption of stearic acid compared to the rapid absorption of lauric acid. 
These may partially explain the different cholesterol raising effects of beef tallow 
and coconut oil. 
 From our results it is clear that modified groups had significantly lower 
level of blood triglyceride than that of the coconut oil groups. Modified beef tallow 
further lowered the blood TG levels when the fat content in the diet was high. In 
present study, we did not examine the mechanisms that produced these 
differences of triglyceride levels among the groups. But a possible explanation 
could be found from a related study by Hu et all (66) who used sunflower oil and 
beef tallow in their experiment and found similar results of reduced triglyceride 
levels by decreasing the chylomicrons size in the diet containing beef tallow. 
Lower digestibility of beef fat could be attributed as a possible explanation of this 
lower production of chylomicrons (66). A study by Mattson (67) also indicated that 
absorbability of the various triacylglycerol of stearic acids was directly related to 
the concentration of stearic acid in the sn-2 position. When stearic acid is 
esterified at the sn-2 position, it is well absorbed. But if it is esterified at the sn-1 or 
the sn-3 position, triacylglycerol is released as free stearic acid and poorly 
absorbed. Thus by altering the position of the stearic acids in the triglyceride 
molecule, the absorption levels will be significantly changed. In beef tallow, the 
stearic acids are more likely in the sn-1 and sn-2 position. This may have lowered 
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the absorption of beef tallow and support the findings reported by Imaizumi et al 
(61) indicating that stearic acid increased fecal sterol excretion. In a separate 
study Grundy (68) showed that hamsters that were fed stearic acid instead of 
palmitic acid had significantly enhanced activity of hepatic LDL receptor and 
reduced concentration of plasma cholesterol. In our present study we did not 
measure the LDL receptor activity but our results suggest that the low levels of 
triglyceride were observed due to the influence of modified beef tallow that was 
given in a high fat diet. On the other hand, lauric acid absorbed rapidly and 
contributed to the increased triglyceride concentration. Rapid clearance of these 
particles might be another prominent factor as well (65).     
   An important finding in our study was that modified high fat groups weighed 
significantly less (Figure1) than the Coconut groups. It is well established that 
medium chain fatty acids are easily oxidized compared to long chain fatty acids, 
leads to greater energy expenditure, results in less bodyweight and decreased 
size of fat depots (69). Our results have shown that rats fed with a fat diet made 
with modified fat (beef tallow) did not gain as much as the coconut oil group 
weight. Logically we would expect that because of the influence of long chain fatty 
acids (here stearic acid) modified groups will gain much more. But our results did 
not show that. Thus the only possible explanation for this result could be attributed 
to the reduced absorption of stearic acid in the beef tallow. 
The difference in body fat % was also examined (Figure 3) in our study. 
Based on the results modified high fat group had significantly lower body fat % 
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than the other 3 groups. There are couple of possibilities that may influence the 
body fat %. Stearic acid might be oxidized efficiently and did not contribute to 
increase body fat % in MFH group but we did not measure fat oxidation so we 
cannot conclude on that aspect. We have also measured energy intake to find out 
if there is any relation between body weight and food intake. Our results showed 
that there were no significant differences among the four diet groups regarding 
energy intake (Figure 4). It is well known that if the concentration of leptin 
increases, it sends a signal to reduce the food intake and increase the energy 
expenditure (70).  But in our study leptin did not influence the change in body 
weight. Reduced leptin levels that we observed in modified groups is due to 
reduced body fat. A relative decrease in leptin levels would be expected to lead 
moderate weight gain but we did not observe this in MHF group. Thus it is 
possible that stearic acid is poorly absorbed and most of the fat was excreted 
through feces and thus contributed to lose more % fat when the fat content was 
high in modified group.  
High fat diets cause insulin resistance and certain fatty acids differ on their 
adverse effects on insulin actions (41). Insulin secretion is increased by long 
chain fatty acids with a high degree of saturation. Different fatty acids can alter 
some of the activities of cell membranes which play a major role in metabolism. A 
smaller change in fatty acid composition can make a strong modification in the 
function of cell membrane. Efficient signal function through these cell membranes 
depends on the specific position and orientation of fatty acid composition of cell 
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membrane (43). Thus specific fatty acid can modify membrane fluidity and 
stiffness and play a key role by controlling the function of insulin signaling. Based 
on our results (Table 3), Modified group had significantly lower insulin but similar 
glucose levels compared to Coconut groups, and implies that modified fat did not 
have any adverse effects on insulin function. We did not observed any change in 
insulin sensitivity among the groups. If we had prolonged our study we would 
have observed a significant difference in insulin sensitivity .Further studies are 
needed to derive a definite conclusion concerning different SFAs and insulin 
sensitivity. 
Table 3 refers that leptin concentration were significantly lower in MHF 
compared to all other 3 groups. No difference between the four groups was 
observed when leptin is expressed in per unit body fat. Thus the change in leptin 
levels was not due to changes in leptin sensitivity, but rather the reduction in body 
fat content.   
Adiponectin is categorized as a special form of anti-inflammatory adipokine 
which controls insulin sensitivity (71). A relationship has been identified between 
cardiovascular risk factors and insulin resistance with hypoadiponectinaemia due 
to obesity (72). In our study, the type of fatty acid (quality) had a marked impact 
on adiponectin levels. Modified fat had significantly high level of adiponectin 
compared to Coconut groups. This difference may be explained due to the type of 
fatty acid that we used in our study. Earlier study by Tomas et al (73) reported that 
adiponectin decreases weight gain by increasing fatty acid oxidation in muscle via 
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AMPK activation through Adipo R1 and acetyl –CoA carboxylase inhibition. 
Another study by Yamauchi et al (74) also reported that adiponectin is unique in 
itself because it lowers triglyceride, body weight and blood glucose levels and 
improve insulin sensitivity which also support our findings. According to them 
adiponectin increases the acyl CoA oxidase, uncoupling protein -2 in muscle,  
and increase gene expression of fat- combustion-related substances like CD36 
and through these mechanisms adiponectin improves blood parameters. These 
mechanisms may also explain our results. But comprehensive studies are needed 
to get a better understanding of the mechanisms of adiponectin function and 
confirm our findings. 
Finally, modified beef tallow that we used in our current study proved to 
have a” neutral” effect on plasma cholesterol profile and this modified beef tallow 
is different from most of the other saturated fats Future studies should aim to 
identify the additional benefits of beef tallow that can be used for long term weight 
management and glucose management. A large sample size and prolonged 
duration of feeding would have decreased variability and might have increased 
the potential of detecting other metabolic differences. Each specific saturated fatty 
acid has different biosynthetic pathways. Specific enzymes that metabolize these 
different types of fatty acids can also vary significantly.  It is very clear that the 
‘type’ of fat (quality) matters more than the amount of fat (quantity) when 
comparing the effects of lauric acid and stearic acid. More research is needed to 
further delineate the mechanisms that stearic acid exerts its beneficial health 
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effect. 
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Figure 1: Body weight of the four rat groups (Mean ± SEM)) 
Note: Asterisk (*) indicates MHF is significantly different (P <0.05) when 
compared to CLF, CHF, MLF. There is no difference noted among the  
MLF, CHF and CLF groups. 
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Figure2: Body fat as percent of total body weight of the four rat groups  
(Mean ± SEM)  
Note: Asterisk (*) indicates MHF is significantly different (P <0.05) when 
compared to CLF, CHF, MLF .There is no difference noted among the  
MLF, CHF and CLF groups. 
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Figure 3: Total body fat content of the four rat groups (Mean ± SEM) 
Note: Asterisk (*) indicates MHF is significantly different (P <0.05) when 
compared to CLF, CHF, MLF. There is no difference noted among the 
MLF, CHF and CLF groups. 
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Figure 4: Energy intake of the four diet groups (Mean ± SEM)  
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Table1: Composition of the diets used in this study 
Modified AIN-93M purified Rodent Diet with 
Low fat, High fat, and Modified Low, Modified High Fat 
 Control Modified Beef Tallow 
Ingredient 
(low fat) (high fat) (low fat) 
 
(high fat) 
 
Gram/kg 
Casein 140 200 140 360 
Cornstarch 465.392 141.52 465.392 46.395 
Dyetrose 155 97.37 155 40 
Maltose Dextrin 100 80 100 40 
Cellulose 50 65 50 65 
Soybean oil 10 10 10 10 
Coconut Oil 30 230 - - 
Modified Beef 
Tallow 
- - 30 230 
Salt mix#210050 35 45.5 35 90 
Vitamin 
Mix#310025 
10 13 
10 
26 
Choline 
Bitartrate 
2.5 3.25 
2.5 
3.25 
L-Cystine 1.8 3.9 1.8 3.9 
Vitamin E 
(500IU/g) 
0.3 0.39 
0.3 
0.39 
TBHQ 0.008 0.07 0.008 0.065 
Source: Dyets inc-2508 Easton A Bethlehem, Pennsylvania 18017 
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Table2: Fatty acid composition in coconut oil and modified beef tallow 
 Coconut oil Modified Beef tallow 
Lauric(12:0) 48.5 .01 
Myristic (14:0) 17.6 3.3 
Palmitic (16:0) 8.4 25.5 
Palmitoleic(16:1) - 3.4 
Stearic (18:0) 2.5 21.6 
Oleic (18:1) 6.5 38.7 
Linoleic (18:2) 1.5 2.2 
Lenolenic(18:3) - 0.6 
Arachidic(20:0) 0.1 0.1 
Arachidonic(20:4) - 0.4 
 
Source: Chow, CK. Fatty acids in foods and their health implication, 3rd edition. 
 CRC Press, Boca Raton, FL. 2008 
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Table 3: Blood parameters of two Coconut groups and two modified groups 
of Wister rats (Mean±SEM) 
 
Group CLF CHF MLF MHF P= 
     Type Amount Interact 
        
        
TC 
(mg/dl) 
152±33 160±24 156±49 195±57 ns ns ns 
TG 
(mg/dl) 
222±12a 245±14a 176±20b 137±38c 0.0001 
 
 
ns 
 
0.0001 
GL 
(mg/dl) 
141±13 128±14 134±19 140±25 ns ns ns 
INS 
(U/ml) 
51.5±8.7 52.2±7.7 44.8±7.3 44.2±14.7 0.026 
 
ns ns 
        
INS Sen 35.9±7.1 33.1±6.4 29.9±6.0 32.3±16.5 ns ns ns 
        
LEPTIN 
(ng/ml) 
9.4±5 a 11±6.8 b 10.2±4 a 4.1±.5c 0.032 
 
ns 0.009 
ADIPONECTIN 
(ng/ml) 
7±.1.6 a   7±.2. a 8±.85 a 10±.2.8 b 0.03 
 
 
ns ns 
 
Values with different superscript (a,b,c) in each row are significantly different from 
each other (p<.05) or (p<0.01). 
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CHAPTER 6 
Conclusion 
Due to the interactions between genes, unhealthy dietary intakes, lack of 
physical activities and other environmental factors, obesity and diabetes have 
become major threats to health in our society now. In USA obesity has become 
the second leading cause, after smoking, of death which could be prevented (75). 
Since different fatty acids have different metabolic activities, dietary fat 
composition can contribute to the development of obesity and other metabolic 
abnormalities by changing fat absorption, oxidation and/or excretion thus 
influence both body weight and composition. HF diet intake has been repeatedly 
shown to play significant role in obesity. Therefor the review of different types of 
fatty acids, their effects on our body weight and regulation has become a major 
issue these days. Previous studies mostly focused on the effects of dietary SFAs 
which generally increase blood cholesterol concentration but it has become 
important now to investigate further regarding the effects of specific fatty acids in 
a broader health context.  
Modified beef tallow, a fat rich in stearic acid, has no adverse effect on 
plasma cholesterol and glucose levels and also does not increase triglyceride 
levels. Modified beef tallow that we used in the present study does have impact 
on weight gain. This modified beef tallow has beneficial effects when the fat 
content is high. Conforming to previous findings, it is an established fact that beef 
tallow is no longer considered hypercholesterolaemic and does not have any 
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deleterious effect on blood profile when it was major fat source in a high fat diet. 
Beef tallow may increase blood adiponectin levels, thus make it an ideal fat 
source for individuals with insulin resistance or pre-diabetes. 
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ABSTRACT 
COMPARE EFFECTS OF DIETS MADE WITH DIFFERENT  
SATURATED FATTY ACIDS ON BODY WEIGHT REGULATION  
AND METABOLISM IN WISTER RATS. 
by 
DILRUBA FATEMA 
May 2014 
Advisor: Dr. K. L. Catherine Jen 
Major: Nutrition and Food Science 
Degree: Master of Science 
Animal fats are known to cause elevated blood total and low-density- lipoprotein 
(LDL) cholesterol levels in humans and animals. This study was designed to 
investigate the effects of both the quality (coconut oil and a modified beef tallow)  
and quantity (low and high) of dietary fat in body weight regulation and alteration 
of blood parameters in an animal model. Fourty two male Wister rats were 
randomly divided into 4 groups: Coconut Low Fat (CLF, n=10), Coconut High Fat 
(CHF, n=10), Modified Low Fat (MLF, n=11), and Modified High Fat (MLF, n=11). 
They were fed modified AIN -93M purified rodent diet with low fat (40gm fat/kg, 
30gm/kg from coconut oil,10gm/kg soybean oil), high fat(240gm/kg, 230gm/kg 
coconut oil, 10gm/kg soybean oil), modified low fat (40gm/kg, 30gm/kg modified 
beef tallow, 10gm/kg soybean oil) and modified high fat (MHF,240gm/kg, 
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230gm/kg modified beef tallow, 10gm/kg soybean oil) for ten weeks. Body weight, 
body fat content, blood lipid contents and hormones related to obesity and insulin 
sensitivity were determined. MHF group (427±46g) had significantly lower body 
weight than the other 3 groups. Body fat percent was significantly lower in 
modified groups (6.41±2.2%) compared to Coconut groups (7.70±2.2%). Our 
results showed no significant differences in energy intake among the 4 diet 
groups (p>.05). No significant difference was observed among the groups with 
respect to total cholesterol and glucose levels. Modified fat (44.5±10.8 µU/ml) had 
significantly decreased insulin levels than the coconut oil (51.9±8.0 µU/ml). MHF 
had significantly lower leptin than CLF, CHF and MLF groups. Adiponectin levels 
were significantly increased by the modified fat (8.81±2.14ng/ml).In conclusion, 
this modified beef fat had the least adverse effects compared with coconut oil and 
was not hypercholesterolaemic, and did not induce obesity when it was given in a 
high fat diet. 
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